- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/68 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 211/68
Total number of patents in this class: 75
10-year publication summary
|
0
|
2
|
0
|
2
|
0
|
0
|
2
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4754 |
5 |
| Cytokinetics, Inc. | 268 |
4 |
| Alkahest, Inc. | 101 |
3 |
| Ardelyx, Inc. | 112 |
3 |
| Richter Gedeon Nyrt. | 1512 |
3 |
| Zevra Therapeutics, Inc. | 89 |
3 |
| Bristol-myers Squibb Company | 4863 |
2 |
| Janssen Pharmaceutica N.V. | 3612 |
2 |
| Bioinformatics & Molecular Design Research Center | 9 |
2 |
| Bioprojet | 49 |
2 |
| Dekk-Tec, Inc. | 9 |
2 |
| Epizyme, Inc. | 386 |
2 |
| Medigenes Co., Ltd. | 12 |
2 |
| Nerviano Medical Sciences S.r.l. | 256 |
2 |
| Neurocrine Biosciences, Inc. | 400 |
2 |
| Merck Sharp & Dohme LLC | 3751 |
2 |
| Novartis AG | 11254 |
1 |
| Hoffmann-La Roche Inc. | 3267 |
1 |
| LG Chem, Ltd. | 17639 |
1 |
| The Regents of the University of California | 19517 |
1 |
| Other owners | 30 |